Physician profile
Landon C Smith
NPI 1790783322
$374.69
in general payments reported to CMS, 2019-2025
12 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.15 · 2020: $20.03 · 2021: $59.89 · 2022: $53.82 · 2023: $49.43 · 2024: $13.73 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $186.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $121.26 | 2019-2023 | Liletta, Orilissa, Lo Loestrin Fe |
| Channel Medsystems, INC. | $89.56 | 2025 | |
| Evofem Biosciences, INC. | $27.72 | 2021-2022 | |
| Coopersurgical, INC. | $20.29 | 2019 | |
| Scynexis, INC. | $19.27 | 2022 | |
| Sage Therapeutics, LLC | $17.04 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $17.04 | 2025 | Qelbree |
| Applied Medical Resources Corporation | $15.39 | 2019 | |
| Boston Scientific Corporation | $14.93 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $13.73 | 2024 | Caldolor |
| Lupin INC. | $13.11 | 2021 | |
| Intuitive Surgical, INC. | $5.35 | 2023 | Da Vinci Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Landon Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.